Merian Life Sciences ApS: Financial statements 2019
CVR: 40288589
Source: annual report 2019, Danish Business Authority
25/02/2019 – 31/12/2019
Merian Life Sciences ApS (CVR 40288589) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 345,223 and a net result of DKK 233,925. Equity in the 2019 report amounted to DKK 283,925. The solvency ratio was 22.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 345,223
- Profit/Loss
- DKK 233,925
- Equity
- DKK 283,925
- Total Assets
- DKK 1,246,715
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of February 25, 2019, Birgitte Menachem is registered as director of Merian Life Sciences ApS.
As of February 25, 2019, Neil Goldsmith is registered as director of Merian Life Sciences ApS.
Merian Life Sciences ApS was founded on February 25, 2019.
About Merian Life Sciences ApS
Merian Life Sciences ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Menachem and Neil Goldsmith. The company is owned by Birgitte Menachem and Neil Goldsmith. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. Equity in the 2025 report amounted to DKK 2,002,914.